PRESIDENT, CHIEF EXECUTIVE OFFICER
Tom has 30 years of experience in significant leadership and executive management roles at large corporations, mid-caps and start-up companies in the medical device and biotech sectors including leadership positions at Acelity and Hoffmann-La Roche. He has been responsible for billion-dollar global healthcare brands, and the successful development and commercialization of numerous healthcare products. Prior to joining Vitanova, he served as President, Chief Executive Officer and Board Director at Invictus Medical, a start-up healthcare technology company. Tom successfully raised approximately $10 million in financing and directed the full development of a novel healthcare technology from concept to FDA clearance and market entry. He received his B.S. in Biology from Denison University, and his M.B.A. from Indiana Wesleyan University.
Matt Gdovin, Ph.D.
CHIEF SCIENCE OFFICER, FOUNDER
Dr. Gdovin received his PhD in Physiology from Dartmouth College in Hanover, NH. His 21-year research career at the University of Texas at San Antonio (UTSA) focused on pH regulation where he discovered the ability to disrupt intracellular pH regulation in cancer to cause cancer cell death. He is the inventor of VNB’s technology and a leading expert in the field of light-activated intracellular acidosis to cause cancer cell death. Dr. Gdovin has ongoing collaborations with oncology clinicians in the departments of Urology at Mt. Sinai Hospital and UT Health San Antonio. He has significant experience in grant management, as he was the Principal Investigator on 10 grants totaling over 3.2 million dollars and served as the Program Director for a 10-million-dollar National Institutes of Health (NIH) grant.
Greg Espenhover, CPA
CHIEF FINANCIAL OFFICER, CO-FOUNDER
Greg is an entrepreneur and dedicated CPA with over 30 years’ experience in providing accounting, tax, and business consulting services to a diverse set of businesses. Since 1988, he has been a CPA under the Texas State Board of Accountancy. Greg is also a member of the American Institute of Certified Public Accountants, the Texas Society of Certified Public Accountants and holds the Certified Information Technology Professional designation issued by the AICPA. In 1999, Greg became a Shareholder and Partner with Davidson Freedle Espenhover & Overby, P.C., providing accounting, auditing, consulting, and tax services to small to medium size private companies.
Harald Stock, Ph.D.
ADVISOR, BOARD DIRECTOR
Harald is a healthcare entrepreneur, investor, board director and serial CEO. After obtaining his Ph.D. in Inorganic Chemistry from Heidelberg University in 1997, he spent over ten years in Big Pharma/Medical Technology at Roche and Johnson & Johnson. From 2009 to 2013 he was CEO of Germany-based Grünenthal Group. In 2014, he was CEO of Sweden-based ArjoHuntleigh. In 2016, he was CEO of Waltham, MA based OvaScience (NASDAQ: OVAS). Harald is currently a board member at Tübingen GER and at Houston, Texas-based Immatics Biotechnologies, a clinical-stage immuno-oncology company. As well, he is a board member at Cambridge, Massachusetts-based Quantum Diamond Technologies, a strategic advisor at ClaimIt! Inc., and he is the co-founder of CognifiSense.